MRSA Infection Outbreak Linked to Boston Hospital’s Infection Control

Since November 2008, dozens of mothers and newborn babies have developed hospital MRSA infections after being treated at Beth Israel Deaconess Medical Center in Boston, which has been cited for lapses in the hospital’s infection control practices.

So far, at least 18 mothers and 19 newborns have been diagnosed with MRSA infections, with 10 of the cases requiring additional hospitalization and two involving serious complications.

Massachusetts state health officials indicate that the only common factor among the patients with MRSA infections was treatment at Beth Israel Deaconess Medical Center.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

An investigation which began in December, has uncovered serious problems with the infection control practices at the hospital, including inadequate cleaning of surfaces used during minor surgery, re-use of medical instruments on multiple babies without properly sterilizing or disinfecting them and poor training of nurses on how to transfuse blood in newborns.

Hospital MRSA infection, also known as methicillin-resistant Staphylococcus aureus, is a type of staph infection that does not respond to most antibiotics. The bacteria is carried in the nose or on the skin, and can be very dangerous once it reaches the organs or bloodstream.

If it is not diagnosed early and treated promptly, MRSA infection outbreaks can spread quickly and may impact vital organs, such as the heart or lungs. In serious cases, individuals who survive the infection can be left with permanent problems, such as loss of limbs, hearing or loss of use of vital organs.

State health officials have not been able to establish the source of the outbreak, and have asked the U.S. Centers for Disease Control and Prevention to assist in the investigation.

The federal Centers for Medicare and Medicaird Services are also planning to conduct a comprehensive review of the practices at the Boston hospital.

Beth Israel Deaconess Medical Center has been asked by the Massachusetts Public Health Department to come up with an immediate plan for correcting its infection control system by today. The hospital’s delivery of babies has not been temporarily halted, as the number of infections is very small in comparison to the 5,000 deliveries every year at the hospital.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted 4 days ago)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.